Mannatech (NASDAQ:MTEX) Share Price Passes Above 200 Day Moving Average – What’s Next?

Mannatech, Incorporated (NASDAQ:MTEX)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.73 and traded as high as $6.60. Mannatech shares last traded at $6.25, with a volume of 4,190 shares.

Analysts Set New Price Targets

Separately, Weiss Ratings raised Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, August 6th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Mannatech has a consensus rating of “Sell”.

Mannatech Stock Up 1.6%

The business’s 50-day moving average is $5.09 and its two-hundred day moving average is $5.73. The company has a market capitalization of $12.06 million, a P/E ratio of -1.60 and a beta of 0.73.

Mannatech (NASDAQ:MTEX) last released its quarterly earnings results on Wednesday, August 12th. The company reported $0.53 earnings per share for the quarter. The business had revenue of $26.65 million for the quarter. Mannatech had a negative net margin of 6.90% and a negative return on equity of 2,383.34%.

Insider Buying and Selling at Mannatech

In other Mannatech news, Director Kevin Andrew Robbins bought 7,100 shares of Mannatech stock in a transaction dated Tuesday, May 19th. The stock was bought at an average cost of $4.17 per share, with a total value of $29,607.00. Following the completion of the acquisition, the director directly owned 33,333 shares in the company, valued at approximately $138,998.61. The trade was a 27.07% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In the last quarter, insiders purchased 14,903 shares of company stock valued at $62,155. 47.50% of the stock is owned by insiders.

Mannatech Company Profile

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.